Crystalys Therapeutics has dosed the first patient with its once daily oral, URAT1 inhibitor dotinurad in its Phase II AMETHYST trial (NCT07535034), designed to assess dotinurad’s effectiveness in ...
Aarti Pharmalabs Ltd (BOM:543748) reported a 9% year-over-year increase in Q4 revenue, reaching Rs 580 crore. The Xanthine derivative segment achieved its highest-ever quarterly revenue, contributing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results